Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors
David Bryant is a highly experienced international pharmaceutical executive with over 35 years in the industry. He has a strong track record in commercial leadership roles at GSK and Pfizer and was one of the original management team at Clinigen Group, from its 2012 IPO on AIM to its sale for $1.6bn in 2022. David is currently an Advisor to Healthcare Royalty (HCRx), a US-based healthcare focused private investment business.
Richard Hughes has had a long and successful career in UK capital markets with over 30 years' corporate finance experience, including IPOs, equity capital raising and M&A for both public and private companies. He was previously a founder shareholder and a director of boohoo.com and a majority shareholder of Crawford Healthcare, a UK-based advanced wound care and dermatology company, which was acquired by Acelity in June 2018. He is a shareholder and director of numerous private companies operating across a range of sectors. Richard founded Zeus Capital, an independent financial services group, in 2003 and is a director of Zeus Group.
Shaun Chilton, Non-Executive Chairman, commented:
'As Avacta completes its transformation into a dedicated pure play therapeutics company, focused on advancing our unique pre|CISION® platform for the benefit of patients, it needs seasoned and expert guidance. David and Richard have many years' experience and proven track records in pharmaceutical development and commercialization and capital markets respectively. Their collective expertise will significantly enhance the Board's capabilities as we focus on the strategic opportunities within our innovative pipeline to build long-term shareholder value.'
commented:
'I am looking forward to working closely with the executive management team on Avacta's exciting technology and leveraging my commercial expertise. With the recent advances from the pre|CISION platform just published and the second program entering the clinic soon, the timing is ideal for me to join the Board.'
added:
'I am delighted to be appointed as a Director. The business has a proprietary delivery platform in pre|CISION® that I believe will have a significant impact on the standard of care across a range of therapeutics, whilst limiting the harmful side effects that so many patients experience. I look forward to utilizing my experience in both fundraising and the scaling of businesses to assist the executive management team in delivering value for all shareholders.'
For further information from Avacta Group plc, please contact:
Avacta Group plcMichael Vinegrad, Group CommunicationsDirector
www.avacta.com
Peel Hunt (Nomad and Joint Broker)James Steel / Chris Golden
www.peelhunt.com
Panmure Liberum (Joint Broker)Emma Earl / Will Goode / Mark Rogers
www.panmureliberum.com
ICR HealthcareMary-Jane Elliott / Jessica Hodgson / Stephanie Cuthbert
avacta@icrhealthcare.com
Investor ContactRenee Leck THRUST Strategic Communications
renee@thrustsc.com
Media ContactCarly ScadutoCarly Scaduto Consulting
Carly@carlyscadutoconsulting.com
About Avacta - www.avacta.comAvacta Therapeutics is a clinical-stage life sciences company expanding the reach of highly potent cancer therapies with the pre|CISION® platform. pre|CISION® is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate highly potent warheads in the tumor microenvironment while sparing normal tissues. Our innovative pipeline consists of pre|CISION® peptide drug conjugates (PDC) or Affimer® drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing unique benefits over traditional antibody drug conjugates.
About the pre|CISION® PlatformThe pre|CISION® platform comprises an anticancer payload conjugated to a proprietary peptide that is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The pre|CISION® platform harnesses this tumor specific protease to cleave pre|CISION® peptide drug conjugates and pre|CISION® antibody/Affimer® drug conjugates in the tumor microenvironment, thus releasing active payload in the tumor and reducing systemic exposure and toxicity, allowing dosing to be optimized to deliver the best outcomes for patients.
Appendix 1: Further disclosures regarding David Bryant
Avacta also discloses the following information in accordance with Schedule 2(g) of the AIM Rules for Companies.
Full name: David John Bryant
Age: 58 years
Current directorships/partnerships:
60 Niton Street (Freehold) Limited
60 Niton Street RTM Ltd
Mulberry Capital Management Ltd
Previous directorships/partnerships held in the past 5 years:
Clinigen Limited
Nupharm Group Limited
Pern Consumer Products Limited
Protomed Limited
Quantum Pharma 2014 Limited
Quantum Pharmaceutical Limited
Quantum Pharma Group Limited
Quantum Pharma Holdings Limited
Quantum Specials Trustee Limited
Triley Bidco Limited
Triley Midco Limited
Triley Midco 2 Limited
U L Medicines Limited
Protomed Limited entered into a creditors' voluntary winding up process in February 2019. There were no secured or preferential creditors and as at April 2025 claims of c. £4.1m from unsecured creditors had been received which were in the process of being agreed and distributed.
David Bryant does not hold any ordinary shares in Avacta.
There are no other disclosures required in connection with the appointment David John Bryant under Schedule Two(g) of the Aim Rules for Companies.
Appendix 2: Further disclosures regarding Richard Hughes
Avacta also discloses the following information in accordance with Schedule 2(g) of the AIM Rules for Companies.
Full name: Richard Ian Hughes
Age: 57 years
Current directorships/partnerships:
Andratx Property Limited
Bidco 2 Limited
Bidco 3 Limited
Bidco 4 Limited
Dakarts Limited
Elpis Holdings Limited
Eternal Time Limited
Irwell Investments Limited
Medusa 19 Limited
Medusa 19 Group Limited
Medusa 19 Healthcare Limited
Medusa Asset Management Limited
Medusa Management Services Limited
Medusa Partners LLP
Oakdate Limited
Palatine Private Equity LLP
RHDL Limited
Saturn Asset Management Limited
Saturn Group Holdings Limited
Saturn Pass Limited
Saturn Passport Limited
Stratford Place Property Investments Ltd
Zeus Group Limited
Previous directorships/partnerships held in the past 5 years:
Newco (Huntingdon Street Nottingham) Limited
The following disclosures are made in accordance with paragraphs (g) (v) and (vi) of Schedule Two of the AIM Rules:
Richard Hughes was:
appointed a director of Catalyst Securities Limited on 3 February 2006, a company incorporated in England. The company was placed into administration on 21 April 2011 and was subsequently dissolved on 14 November 2018, with approximately £9.3 million owing to creditors;
appointed a director of Catalyst Securities No.2 Fund Limited on 3 February 2006, a company incorporated in England. The company was placed into administration on 13 September 2010 and was subsequently dissolved on 15 June 2013, with approximately £1.5 million owing to creditors;
appointed a director of Catalyst Investments Limited on 18 January 2006, a company incorporated in England. The company entered a creditors' voluntary liquidation on 17 June 2011 and was subsequently dissolved on 23 April 2014, with approximately £9.5 million owing to creditors;
appointed a director of Procurasell Holdings Limited on 30 October 2007, a company incorporated in England. The company entered a compulsory liquidation on 17 June 2009 and was subsequently dissolved on 24 August 2010;
appointed a director of The Debt Advisor Group plc on 9 April 2003, a company incorporated in England. The company was placed into administration on 29 June 2007 and was subsequently dissolved on 10 April 2011, with approximately £2.3 million owing to unsecured creditors;
appointed an LLP designated member of My SPA Liverpool LLP, a limited liability partnership incorporated in England, on 5 November 2008. The partnership entered a creditors' voluntary liquidation on 20 October 2009 and was subsequently dissolved on 25 May 2011, with an estimated £64,633 owing to unsecured creditors; and
appointed an LLP designated member of My SPA Chesire LLP, a limited liability partnership incorporated in England, on 1 December 2008. The partnership entered a creditors' voluntary liquidation on 22 April 2010 and was subsequently dissolved on 16 July 2012, with approximately £31,000 owing to unsecured creditors.
Richard Hughes does not hold any ordinary shares in Avacta.
There are no other disclosures required in connection with the appointment Richard Ian Hughes under Schedule Two(g) of the Aim Rules for Companies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Smart Reads of the Week: Top Stocks, REITs, and Market Moves to Watch
The stock market continues to power ahead, with both Singapore and US equities presenting fresh opportunities. From top-performing stocks of the past decade to high-potential growth plays riding the AI and digitalisation wave, this week's selection covers strategies for both capital gains and income investors. We also explore the winners and losers from Singapore's telco shake-up, and highlight blue-chip and REIT ideas for long-term portfolios. Here are this week's top articles: The Top 10 Singapore Stocks Over the Past Decade – And Which Ones Still Look Good TodayA look back at the biggest winners over the last 10 years – and which ones could continue delivering strong returns in the years ahead. The Bull Market is Raging On: Should You Buy, Sell, or Hold Your Shares?With markets hitting new highs, we explore how to decide whether to lock in profits, stay invested, or add to your positions. 4 Singapore REITs Unlocking Value to Boost Their DPUThese REITs are enhancing their portfolios through acquisitions, asset enhancements, and strategic moves to grow unitholder returns. 5 US Technology Growth Stocks to Ride the Digitalisation and AI WavesFrom cloud computing to AI, these US tech stocks are well-placed to benefit from powerful secular trends. Singapore's Telco Consolidation: Who Are the Winners and Losers?The local telco landscape is evolving fast – here's what it means for the major players and their investors. Earn While You Sleep: Build Passive Income with These 3 Singapore Dividend StocksLooking for reliable dividend payers? These companies offer a steady stream of income alongside capital stability. 4 Singapore Blue-Chip Stocks That You Can Own for LifeStalwarts with enduring business models that could anchor your portfolio for decades. SGX Added Two More Hong Kong Singapore Depository Receipts: Here's What You Need to KnowAn update on SGX's growing list of Hong Kong SDRs, offering investors a gateway to more cross-border opportunities. Here's the best way to spend 5 minutes each week: Smart Reads. It gives you a fast, focused investing roundup so you don't waste hours scrolling through the news. We handpick the best stories, ideas, and market updates that matter. Whether it's dividend gems, capital growth plays, or key market shifts, you get them all in one email for free. Click here to join our community in Smart Reads, your smartest 15-minute read of the week. Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses! The post Smart Reads of the Week: Top Stocks, REITs, and Market Moves to Watch appeared first on The Smart Investor. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Bradford now one of FOUR hubs as Yorkshire and Vertu boost community cricket
A major boost for grassroots cricket has been delivered this week as automotive giant Vertu strengthened its ties with Yorkshire County Cricket Club to help expand the successful Cric-Kit initiative, which has already seen great success in Bradford. The programme, run by the Yorkshire Cricket Foundation, has gone from strength to strength since its launch in 2022, offering a lifeline to budding cricketers by redistributing donated equipment to communities across the region. Now, thanks to Vertu's continued backing, a fourth Cric-Kit hub has officially opened in York. The scheme, which started with a year-long pilot, already operates out of Bradford, Leeds and Sheffield. Cricket fans and former players have been encouraged to donate unwanted gear, including bats, pads, helmets and more, which the Foundation then refurbishes and reallocates to those facing financial or social barriers to playing. Robert Forrester, Chief Executive of Vertu, said the expansion underlines the company's commitment to supporting community sport across the county. Vertu have strong tie-ins with Yorkshire County Cricket Club, while they are the current sponsors of the EFL Trophy too. (Image: Recognition PR) 'We are delighted to work with the Yorkshire Cricket Foundation to expand the hugely successful Cric-Kit initiative,' he said. 'Having already helped break down some of the barriers that prevented people from participating in the sport, we look forward to widening the reach of the programme to allow more people to get involved with the creation of the fourth hub. 'This is a central part of the work that the Foundation does in the community, and we share their passion to help boost the number of people who are able to play the game.' The new York hub will not only increase the initiative's geographical footprint but is also expected to serve hundreds more aspiring cricketers from underrepresented backgrounds. Sohail Raz, Diverse Communities Manager at the Yorkshire Cricket Foundation, welcomed the development. 'We're incredibly proud to see the Cric-Kit initiative extend its reach to a new hub in York, breaking down further barriers and making cricket accessible to all,' he said. 'This expansion would not be possible without the continued commitment of Vertu whose support is helping the Yorkshire Cricket Foundation create a lasting impact across communities. 'Together we're ensuring that no cricketer is held back from playing the game they love because of the cost or lack of access to cricket equipment.' With cricket participation continuing to grow across Yorkshire, the Cric-Kit scheme is seen as a crucial part of the county's efforts to make the game more inclusive, and ensure everyone, regardless of background, has the chance to take part.
Yahoo
an hour ago
- Yahoo
Suncorp Group (ASX:SUN) Will Pay A Dividend Of A$0.49
The board of Suncorp Group Limited (ASX:SUN) has announced that it will pay a dividend of A$0.49 per share on the 24th of September. Based on this payment, the dividend yield on the company's stock will be 4.3%, which is an attractive boost to shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Suncorp Group's Future Dividends May Potentially Be At Risk A big dividend yield for a few years doesn't mean much if it can't be sustained. The last dividend was quite easily covered by Suncorp Group's earnings. This means that a large portion of its earnings are being retained to grow the business. Looking forward, earnings per share is forecast to fall by 13.6% over the next year. If the dividend continues along recent trends, we estimate the payout ratio could reach over 200%, which could put the dividend in jeopardy if the company's earnings don't improve. Check out our latest analysis for Suncorp Group Dividend Volatility The company has a long dividend track record, but it doesn't look great with cuts in the past. The dividend has gone from an annual total of A$1.31 in 2015 to the most recent total annual payment of A$0.90. This works out to be a decline of approximately 3.7% per year over that time. Generally, we don't like to see a dividend that has been declining over time as this can degrade shareholders' returns and indicate that the company may be running into problems. The Dividend Looks Likely To Grow Growing earnings per share could be a mitigating factor when considering the past fluctuations in the dividend. We are encouraged to see that Suncorp Group has grown earnings per share at 20% per year over the past five years. The company is paying a reasonable amount of earnings to shareholders, and is growing earnings at a decent rate so we think it could be a decent dividend stock. We Really Like Suncorp Group's Dividend In summary, it is good to see that the dividend is staying consistent, and we don't think there is any reason to suspect this might change over the medium term. The company is generating plenty of cash, and the earnings also quite easily cover the distributions. However, it is worth noting that the earnings are expected to fall over the next year, which may not change the long term outlook, but could affect the dividend payment in the next 12 months. All in all, this checks a lot of the boxes we look for when choosing an income stock. Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. To that end, Suncorp Group has 2 warning signs (and 1 which shouldn't be ignored) we think you should know about. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
